Cytokinetics Inc (CYTK)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

280 EAST GRAND AVENUE SOUTH SAN FRANCISCO, CA 94080

Focuses on the discovery, development and commercialization of novel small molecule drugs that target the cytoskeleton. As of March 2006, the company has small moleclue drug candidates in clinical development, and two in preclinical development.

Data as of 2021-05-08 10:32:52 -0400
Market Cap1.733 Billion Shares Outstanding71.537 Million Avg 30-day Volume797.555 Thousand
P/E Ratio-13.61719 Dividend Yield EPS-1.97
Price/Sales31.05 Debt to Equity4.71 EBITDA-92.112 Million
Price to Book Value15.29 Forward PE-9.28 Enterprise Value1.405 Billion
Total Cash464.06 Million Current Debt31.199 Million Gross Profit55.828 Million
BETA1.02689 52-week High/Low30.14 / 14.71 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from CYTK instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 7 -28.57% 4 (0.24%) 7 (0.44%) -42.86%
Funds Holding: 178 181 -1.66% 49 (2.94%) 59 (3.67%) -16.95%
13F shares: 72.917 Million 68.611 Million 6.28% 29.722 Million 30.514 Million -2.6%
% Ownership 96.9375 41.9924 43.1122 -2.6%
New Positions: 38 43 -11.63% 12 17 -29.41%
Increased Positions 58 86 -32.56% 16 22 -27.27%
Closed Positions 40 20 100.0% 23 12 91.67%
Reduced Positions 57 35 62.86% 13 17 -23.53%
Total Calls 589.595 Thousand 2.736 Million -78.45% 275.469 Thousand 1.97 Million -86.02%
Total Puts 357.352 Thousand 2.35 Million -84.8% 91.4 Thousand 1.414 Million -93.54%
PUT/CALL Ratio 0.61 0.86 -29.07% 0.33 0.72 -54.17%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CYTK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CYTK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

103.7 Thousand total shares from 24 transactions

Exercise Derivative Conversion (M)

101.7 Thousand total shares from 23 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BLUM ROBERT I PRESIDENT & CEO

  • Officer
  • Director
405,090 2021-05-07 34

SMITH SANDFORD D

  • Director
15,920 2021-04-27 16

MALIK FADY IBRAHAM EVP RESEARCH & DEVELOPMENT

  • Officer
162,348 2021-04-08 14

HENDERSON JOHN T

  • Director
7,493 2021-04-01 7

GAGE L PATRICK

  • Director
24,379 2021-04-01 7

WIERENGA WENDALL

  • Director
920 2021-04-01 3

KAYE EDWARD M. MD

  • Director
920 2021-04-01 4

CALIFF ROBERT

  • Director
459 2021-04-01 3

WYSENSKI NANCY

  • Director
459 2021-04-01 4

CALLOS ANDREW EVP, CHIEF COMMERCIAL OFFICERS

  • Officer
150,000 2021-03-31 2

CRAGG DAVID SVP HUMAN RESOURCES

  • Officer
160,625 2021-03-08 5

JAW CHING SVP FINANCE & CFO

  • Officer
88,492 2021-03-08 6

SCHLOSSBERG MARK A SVP - LEGAL & GENERAL COUNSEL

  • Officer
50,850 2021-03-08 4

WONG ROBERT VP, CHIEF ACCOUNTING OFFICER

  • Officer
23,879 2021-03-08 2

BHANJI MUNA

  • Director
0 2021-02-17 2

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BVF I GP LLC

BIOTECHNOLOGY VALUE FUND II LP

BVF II GP LLC

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF GP HOLDINGS LLC

BVF INC/IL

LAMPERT MARK N

  • SEE EXPLANATON OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
7,034,700 2020-12-09 1

COSTA SANTO J

  • Director
0 2020-10-05 3

PARSHALL B LYNNE

  • Director
0 2020-10-05 3

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
424,419 2020-02-13 3

MCDOWELL CARYN GORDON GC & CHIEF COMPLIANCE OFFICER

  • Officer
32,548 2018-02-27 0

RODDY PETER S SVP FINANCE & CAO

  • Officer
21,520 2018-02-27 0

MORGAN BRADLEY PAUL SVP DRUG DISCOVERY & EARLY DEV

  • Officer
46,441 2017-08-31 0

WOLFF ANDREW A SVP & CMO

  • Officer
47,255 2017-02-28 0

BARBARI SHARON SURREY EVP, FINANCE & CFO

  • Officer
40,323 2017-02-28 0

CHARPENTIER BONNIE SVP REGULATORY & COMPLIANCE

  • Officer
29,004 2017-02-28 0

SCHNIEDERS ELISABETH SR. VP, BUSINESS DEVELOPMENT

  • Officer
43,919 2017-02-28 0

GILBERT DENISE

  • Director
No longer subject to file 2015-05-20 0

EASTERN CAPITAL LTD

PORTFOLIO SERVICES LTD.

DART KENNETH BRYAN

  • 10% Owner
No longer subject to file 2014-02-25 0

DOW STEPHEN M

  • Director
0 2013-01-02 0

EASTERN CAPITAL LTD

  • 10% Owner
14,303,071 2012-06-20 0

SPUDICH JAMES A

  • Director
180,600 2011-05-18 0

MORGANS DAVID J JR EVP-PRECLINICAL R&D

  • Officer
42,000 2011-02-28 0

HEIDRICH A GRANT III

  • Director
0 2011-01-03 0

SCHMERTZLER MICHAEL

  • SEE EXHIBIT 1
No longer subject to file 2010-11-01 0

SABRY JAMES H

  • FORMER EXECUTIVE CHAIRMAN
No longer subject to file 2010-06-03 0

RABSON MICHAEL SVP BUSINESS DEV/LEGAL & GC

  • Officer
20,043 2009-12-18 0

MCDADE MARK

  • Director
0 2009-05-21 0

HOMCY CHARLES J

  • Director
0 2008-05-22 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2021-05-07 18:46:13 -0400 2021-05-07 S 5,000 $23.21 d 356,859 direct yes

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2021-05-07 18:46:13 -0400 2021-05-07 M 5,000 $6.30 a 361,859 direct yes

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2021-05-07 18:46:13 -0400 2021-05-07 M 5,000 d 44,065 direct yes

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2021-04-30 17:46:07 -0400 2021-04-30 S 5,000 $25.87 d 356,859 direct yes -6.4429 0.0 1 -6.4429 2

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2021-04-30 17:46:07 -0400 2021-04-30 M 5,000 $6.30 a 361,859 direct yes -6.4429 0.0 1 -6.4429 2

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2021-04-30 17:46:07 -0400 2021-04-30 M 5,000 d 49,065 direct yes

SMITH SANDFORD D - Director

2021-04-27 17:40:05 -0400 2021-04-27 M 4,739 d 0 direct yes

SMITH SANDFORD D - Director

2021-04-27 17:40:05 -0400 2021-04-27 S 4,739 $27.50 d 920 direct yes -2.0779 -12.5046 0.0 1 -12.5046 6

SMITH SANDFORD D - Director

2021-04-27 17:40:05 -0400 2021-04-27 S 5,000 $28.00 d 920 direct yes -2.0779 -12.5046 0.0 1 -12.5046 6

SMITH SANDFORD D - Director

2021-04-27 17:40:05 -0400 2021-04-27 M 4,739 $10.55 a 5,659 direct yes -2.0779 -12.5046 0.0 1 -12.5046 6

SMITH SANDFORD D - Director

2021-04-27 17:40:05 -0400 2021-04-27 M 5,000 d 15,000 direct yes

SMITH SANDFORD D - Director

2021-04-27 17:40:05 -0400 2021-04-27 M 5,000 $10.68 a 5,920 direct yes -2.0779 -12.5046 0.0 1 -12.5046 6

SMITH SANDFORD D - Director

2021-04-27 16:47:30 -0400 2021-04-26 M 5,000 d 5,000 direct yes

SMITH SANDFORD D - Director

2021-04-27 16:47:30 -0400 2021-04-26 S 5,000 $27.00 d 920 direct yes -2.0779 -12.5046 0.0 1 -12.5046 6

SMITH SANDFORD D - Director

2021-04-27 16:47:30 -0400 2021-04-26 M 5,000 $9.45 a 5,920 direct yes -2.0779 -12.5046 0.0 1 -12.5046 6

SMITH SANDFORD D - Director

2021-04-23 17:32:58 -0400 2021-04-23 M 5,000 d 10,000 direct yes

SMITH SANDFORD D - Director

2021-04-23 17:32:58 -0400 2021-04-23 S 5,000 $26.50 d 920 direct yes -0.8522 -3.9644 0.0 1 -5.7429 5

SMITH SANDFORD D - Director

2021-04-23 17:32:58 -0400 2021-04-23 M 5,000 $9.45 a 5,920 direct yes -0.8522 -3.9644 0.0 1 -5.7429 5

SMITH SANDFORD D - Director

2021-04-15 18:55:34 -0400 2021-04-15 M 5,000 d 15,000 direct yes

SMITH SANDFORD D - Director

2021-04-15 18:55:34 -0400 2021-04-15 M 5,714 $8.75 a 6,634 direct yes 0.1215 7.247 7.247 6 0.0 1

SMITH SANDFORD D - Director

2021-04-15 18:55:34 -0400 2021-04-15 M 5,714 d 0 direct yes

SMITH SANDFORD D - Director

2021-04-15 18:55:34 -0400 2021-04-15 S 5,000 $25.50 d 920 direct yes 0.1215 7.247 7.247 6 0.0 1

SMITH SANDFORD D - Director

2021-04-15 18:55:34 -0400 2021-04-15 S 5,714 $25.00 d 920 direct yes 0.1215 7.247 7.247 6 0.0 1

SMITH SANDFORD D - Director

2021-04-15 18:55:34 -0400 2021-04-15 M 5,000 $9.45 a 5,920 direct yes 0.1215 7.247 7.247 6 0.0 1

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2021-04-12 17:31:52 -0400 2021-04-12 M 5,000 d 54,065 direct yes

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2021-04-12 17:31:52 -0400 2021-04-12 S 5,000 $23.56 d 356,859 direct yes 1.4638 5.8135 5.8135 6 0.0 1

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2021-04-12 17:31:52 -0400 2021-04-12 M 5,000 $6.30 a 361,859 direct yes 1.4638 5.8135 5.8135 6 0.0 1

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 M 3,207 $6.82 a 4,127 direct yes 1.4638 5.8135 5.8135 6 0.0 1

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 M 4,375 d 0 direct yes

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 M 5,000 d 10,000 direct yes

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 S 4,375 $24.50 d 920 direct yes 1.4638 5.8135 5.8135 6 0.0 1

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 M 5,000 $7.61 a 5,920 direct yes 1.4638 5.8135 5.8135 6 0.0 1

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 S 5,000 $23.80 d 920 direct yes 1.4638 5.8135 5.8135 6 0.0 1

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 M 5,000 $7.61 a 5,920 direct yes 1.4638 5.8135 5.8135 6 0.0 1

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 M 5,000 d 0 direct yes

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 M 5,000 d 15,000 direct yes

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 M 4,375 $10.00 a 5,295 direct yes 1.4638 5.8135 5.8135 6 0.0 1

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 S 5,000 $23.79 d 920 direct yes 1.4638 5.8135 5.8135 6 0.0 1

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 M 5,000 $7.61 a 5,920 direct yes 1.4638 5.8135 5.8135 6 0.0 1

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 S 3,207 $24.00 d 920 direct yes 1.4638 5.8135 5.8135 6 0.0 1

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 M 5,000 d 5,000 direct yes

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 M 3,207 d 0 direct yes

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 S 5,000 $23.79 d 920 direct yes 1.4638 5.8135 5.8135 6 0.0 1

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 M 5,000 $7.61 a 5,920 direct yes 1.4638 5.8135 5.8135 6 0.0 1

SMITH SANDFORD D - Director

2021-04-12 16:21:38 -0400 2021-04-09 S 5,000 $23.79 d 920 direct yes 1.4638 5.8135 5.8135 6 0.0 1

MALIK FADY IBRAHAM - Officer EVP RESEARCH & DEVELOPMENT

2021-04-08 18:12:59 -0400 2021-04-08 S 2,000 $23.39 d 162,348 direct yes -1.2831 2.2351 2.9387 5 -1.2831 2

HENDERSON JOHN T - Director

2021-04-05 18:50:29 -0400 2021-04-01 M 1,100 d 1,100 direct yes

HENDERSON JOHN T - Director

2021-04-05 18:50:29 -0400 2021-04-01 M 1,100 $8.64 a 8,510 direct yes -3.354 -0.9938 0.1656 3 -3.354 2

HENDERSON JOHN T - Director

2021-04-05 18:50:29 -0400 2021-04-01 S 1,133 $24.00 d 7,410 direct yes -3.354 -0.9938 0.1656 3 -3.354 2

CALIFF ROBERT - Director

2021-04-05 17:46:56 -0400 2021-04-01 A 204 $24.44 a 459 direct -3.354 -0.9938 0.1656 3 -3.354 2

SMITH SANDFORD D - Director

2021-04-05 17:47:58 -0400 2021-04-01 A 409 $24.44 a 920 direct -3.354 -0.9938 0.1656 3 -3.354 2

HENDERSON JOHN T - Director

2021-04-05 18:50:29 -0400 2021-04-01 M 1,133 d 2,200 direct yes

HENDERSON JOHN T - Director

2021-04-05 18:50:29 -0400 2021-04-01 S 1,100 $23.31 d 7,410 direct yes -3.354 -0.9938 0.1656 3 -3.354 2

HENDERSON JOHN T - Director

2021-04-05 18:50:29 -0400 2021-04-01 M 1,133 $8.64 a 8,543 direct yes -3.354 -0.9938 0.1656 3 -3.354 2

GAGE L PATRICK - Director

2021-04-05 17:47:14 -0400 2021-04-01 A 767 $24.44 a 22,529 direct -3.354 -0.9938 0.1656 3 -3.354 2

WIERENGA WENDALL - Director

2021-04-05 17:48:24 -0400 2021-04-01 A 409 $24.44 a 920 direct -3.354 -0.9938 0.1656 3 -3.354 2

HENDERSON JOHN T - Director

2021-04-05 18:50:29 -0400 2021-04-01 M 1,100 d 0 direct yes

HENDERSON JOHN T - Director

2021-04-05 18:50:29 -0400 2021-04-01 S 1,100 $23.31 d 7,410 direct yes -3.354 -0.9938 0.1656 3 -3.354 2

HENDERSON JOHN T - Director

2021-04-05 18:50:29 -0400 2021-04-01 M 1,100 $8.64 a 8,510 direct yes -3.354 -0.9938 0.1656 3 -3.354 2

KAYE EDWARD M. MD - Director

2021-04-05 17:47:52 -0400 2021-04-01 A 409 $24.44 a 920 direct -3.354 -0.9938 0.1656 3 -3.354 2

WYSENSKI NANCY - Director

2021-04-05 17:48:41 -0400 2021-04-01 A 204 $24.44 a 459 direct -3.354 -0.9938 0.1656 3 -3.354 2

CALLOS ANDREW - Officer EVP, CHIEF COMMERCIAL OFFICERS

2021-04-05 17:46:12 -0400 2021-03-31 A 150,000 $23.26 a 150,000 direct

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2021-03-24 16:13:39 -0400 2021-03-22 M 566 d 59,065 direct yes

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2021-03-24 16:13:39 -0400 2021-03-22 M 566 $6.30 a 357,425 direct yes -0.5417 1.8333 0.9583 12.4583 22 -6.9583 4

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2021-03-24 16:13:39 -0400 2021-03-22 M 4,434 d 0 direct yes

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2021-03-24 16:13:39 -0400 2021-03-22 S 4,434 $25.19 d 356,859 direct yes -0.5417 1.8333 0.9583 12.4583 22 -6.9583 4

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2021-03-24 16:13:39 -0400 2021-03-22 S 566 $25.19 d 356,859 direct yes -0.5417 1.8333 0.9583 12.4583 22 -6.9583 4

BLUM ROBERT I - Director - Officer PRESIDENT & CEO

2021-03-24 16:13:39 -0400 2021-03-22 M 4,434 $6.00 a 361,293 direct yes -0.5417 1.8333 0.9583 12.4583 22 -6.9583 4

GAGE L PATRICK - Director

2021-03-19 18:55:29 -0400 2021-03-19 M 10,000 d 0 direct

GAGE L PATRICK - Director

2021-03-19 18:55:29 -0400 2021-03-19 S 10,000 $24.45 d 21,762 direct -4.7064 -8.7289 -2.4537 8.568 25 -10.177 7

GAGE L PATRICK - Director

2021-03-19 18:55:29 -0400 2021-03-19 M 10,000 $5.88 a 31,762 direct -4.7064 -8.7289 -2.4537 8.568 25 -10.177 7

GAGE L PATRICK - Director

2021-03-12 18:58:10 -0500 2021-03-12 M 7,006 $5.88 a 28,768 direct -1.6879 2.3466 10.1688 11.1157 30 -8.0692 12

GAGE L PATRICK - Director

2021-03-12 18:58:10 -0500 2021-03-12 M 3,333 d 0 direct

GAGE L PATRICK - Director

2021-03-12 18:58:10 -0500 2021-03-12 M 3,333 $8.64 a 25,095 direct -1.6879 2.3466 10.1688 11.1157 30 -8.0692 12

GAGE L PATRICK - Director

2021-03-12 18:58:10 -0500 2021-03-12 M 7,006 d 10,000 direct

GAGE L PATRICK - Director

2021-03-12 18:58:10 -0500 2021-03-12 S 7,006 $21.22 d 21,762 direct -1.6879 2.3466 10.1688 11.1157 30 -8.0692 12

GAGE L PATRICK - Director

2021-03-12 18:58:10 -0500 2021-03-12 S 3,333 $21.22 d 21,762 direct -1.6879 2.3466 10.1688 11.1157 30 -8.0692 12

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CYTOKINETICS INC CYTK 2021-05-10 22:15:04 UTC -0.2032 0.2532 750000
CYTOKINETICS INC CYTK 2021-05-10 21:45:02 UTC -0.2031 0.2531 750000
CYTOKINETICS INC CYTK 2021-05-10 21:15:02 UTC -0.2031 0.2531 750000
CYTOKINETICS INC CYTK 2021-05-10 20:45:03 UTC -0.2031 0.2531 750000
CYTOKINETICS INC CYTK 2021-05-10 20:15:03 UTC -0.2031 0.2531 750000
CYTOKINETICS INC CYTK 2021-05-10 19:45:03 UTC -0.2031 0.2531 750000
CYTOKINETICS INC CYTK 2021-05-10 19:15:03 UTC -0.2031 0.2531 750000
CYTOKINETICS INC CYTK 2021-05-10 18:45:03 UTC -0.2034 0.2534 750000
CYTOKINETICS INC CYTK 2021-05-10 18:15:03 UTC -0.2034 0.2534 750000
CYTOKINETICS INC CYTK 2021-05-10 17:45:02 UTC -0.2034 0.2534 750000
CYTOKINETICS INC CYTK 2021-05-10 17:15:03 UTC -0.2034 0.2534 750000
CYTOKINETICS INC CYTK 2021-05-10 16:45:03 UTC -0.2057 0.2557 750000
CYTOKINETICS INC CYTK 2021-05-10 16:15:03 UTC -0.2057 0.2557 750000
CYTOKINETICS INC CYTK 2021-05-10 15:45:03 UTC -0.2057 0.2557 750000
CYTOKINETICS INC CYTK 2021-05-10 15:15:03 UTC -0.2057 0.2557 750000
CYTOKINETICS INC CYTK 2021-05-10 14:45:04 UTC -0.2 0.25 750000
CYTOKINETICS INC CYTK 2021-05-10 14:15:04 UTC -0.2 0.25 750000
CYTOKINETICS INC CYTK 2021-05-10 13:45:04 UTC -0.2 0.25 750000
CYTOKINETICS INC CYTK 2021-05-10 13:15:03 UTC -0.2 0.25 750000
CYTOKINETICS INC CYTK 2021-05-10 12:45:02 UTC -0.2 0.25 750000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund CYTK -3.0 shares, $-35.37 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund CYTK -28.0 shares, $-330.12 2020-03-31 N-PORT

Elevate your investments